Abstract

The main goal of the MMC-VICC-TSU Cancer Partnership (MVTCP) training and education program is to increase the number and quality of minority researchers dedicated to making an impact in cancer research.
Our aims are to (1) recruit outstanding minority undergraduate and graduate students and Oncology Fellows to cancer research, (2) provide these trainees with exceptional mentoring and training so that they are equipped to make a difference in the impact of cancer on the population, and (3) motivate them to seek further cancer research training which could lead to development of careers that include cancer research focus. In order to accomplish this goal our partnership will recruit and train 6 Ph.D., 5 MSPH and 5 MPH students in our cancer research programs at MMC and TSU. The Partnership will also support 6 Clinical Oncology Fellows in training in the Vanderbiit Oncology Fellowship Program. Table 1 indicates the proposed number of Ph.D., MSPH/MPH and Clinical Oncology Trainees to be supported by the grant in each year.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163066-02
Application #
8380459
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
2
Fiscal Year
2012
Total Cost
$46,997
Indirect Cost
$22,550

  Institution

Name
Tennessee State University
Department
Type
DUNS #
108814179
City
Nashville
State
TN
Country
United States
Zip Code
37209

  Publications

Vercruysse, Koen; Clark, Astiney; Alatas, Noor et al. (2018) Polysaccharide-mediated synthesis of melanins from serotonin and other 5-hydroxy indoles. Future Sci OA 4:FSO280
Husaini, Baqar A; Taira, Deborah; Norris, Keith et al. (2018) Depression Effects on Hospital Cost of Heart Failure Patients in California: An Analysis by Ethnicity and Gender. Indian J Community Med 43:49-52
Lawrence, Shanieek; Ismail, Farah; Jamal, Sarah Z et al. (2018) Tributyltin stimulates synthesis of interferon gamma and tumor necrosis factor alpha in human lymphocytes. J Appl Toxicol 38:1081-1090
Alotaibi, Dalal; Amara, Suneetha; Johnson, Terrance L et al. (2018) Potential anticancer effect of prostratin through SIK3 inhibition. Oncol Lett 15:3252-3258
Brown, Shyretha; Boules, Mariam; Hamza, Nafisa et al. (2018) Synthesis of interleukin 1 beta and interleukin 6 in human lymphocytes is stimulated by tributyltin. Arch Toxicol 92:2573-2586
Odoh, C; Sanderson, M; Williams, E A et al. (2018) Operationalizing outcome measures of human papillomavirus vaccination among adolescents. Public Health 159:129-132
Yasmin, Sharia; Whalen, Margaret (2018) Flame retardants, hexabromocyclododecane (HCBD) and tetrabromobisphenol a (TBBPA), alter secretion of tumor necrosis factor alpha (TNF?) from human immune cells. Arch Toxicol 92:1483-1494
Brown, Shyretha; Wilburn, Wendy; Martin, Tyesha et al. (2018) Butyltin compounds alter secretion of interleukin 6 from human immune cells. J Appl Toxicol 38:201-218
Massawe, Reda; Drabo, Leon; Whalen, Margaret (2017) Effects of pentachlorophenol and dichlorodiphenyltrichloroethane on secretion of interferon gamma (IFN?) and tumor necrosis factor alpha (TNF?) from human immune cells. Toxicol Mech Methods 27:223-235
Amara, Suneetha; Majors, Ciera; Roy, Bipradas et al. (2017) Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation. PLoS One 12:e0180097

Showing the most recent 10 out of 76 publications